Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: one thing managment is definitely sharing with shareholders

Swartzy would want what drives up the share price too



I disagree. I think in Patriot's case any M & A would involve spending money, which would initially affect the bottom line.



Sudden thought, perhaps Turley came up with a possible M/A and S & L turned it down because they felt that it would have an initial negative effect on SP.

Share
New Message
Please login to post a reply